These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3472465)

  • 1. Treatment of ciprofloxacin- and ceftizoxime-induced resistant gram-negative bacilli.
    Fasching CE; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):80-6. PubMed ID: 3472465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    Bamberger DM; Peterson LR; Gerding DN; Moody JA; Fasching CE
    J Antimicrob Chemother; 1986 Jul; 18(1):51-63. PubMed ID: 3093445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the antimicrobial resistance patterns of gram-negative bacilli isolated from community-private and university-affiliated hospitals from Puerto Rico.
    Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermúdez M; Colón M
    P R Health Sci J; 2003 Sep; 22(3):265-71. PubMed ID: 14619453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit model.
    Peterson LR; Gerding DN; Moody JA; Fasching CE
    Antimicrob Agents Chemother; 1984 May; 25(5):545-52. PubMed ID: 6329087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy and in vitro activity of the ciprofloxacin-azlocillin combination (ratio 1:10) against gram-negative bacteria from non-neutropenic haematologic patients.
    Piccolomini R; Di Girolamo A; Iacone A; Fioritoni G; Cellini L; Nicoletti M; D'Antonio D
    Drugs Exp Clin Res; 1991; 17(9):455-60. PubMed ID: 1822439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
    Debbia E; Soro O
    Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
    Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC
    Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mezlocillin, ceftizoxime, and amikacin alone and in combination against six Enterobacteriaceae in a neutropenic site in rabbits.
    Gerding DN; Peterson LR; Moody JA; Fasching CE
    J Antimicrob Chemother; 1985 Jan; 15 Suppl A():207-19. PubMed ID: 3856563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitis.
    Hessen MT; Ingerman MJ; Kaufman DH; Weiner P; Santoro J; Korzeniowski OM; Boscia J; Topiel M; Bush LM; Kaye D
    Am J Med; 1987 Apr; 82(4A):262-5. PubMed ID: 3555045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activity of ciprofloxacin against amikacin- and cefotaxime-resistant gram-negative bacilli and methicillin-resistant staphylococci.
    Simberkoff MS; Rahal JJ
    Antimicrob Agents Chemother; 1986 Jun; 29(6):1098-100. PubMed ID: 2942105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ciprofloxacin in the treatment of elderly patients with complicated urinary tract infections due to trimethoprim/sulfamethoxazole-resistant bacteria.
    Preheim LC; Cuevas TA; Roccaforte JS; Mellencamp MA; Bittner MJ
    Am J Med; 1987 Apr; 82(4A):295-300. PubMed ID: 3555051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of preclinical studies with ciprofloxacin.
    Sanders CC; Sanders WE; Goering RV
    Am J Med; 1987 Apr; 82(4A):2-11. PubMed ID: 3646829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site model.
    Peterson LR; Moody JA; Fasching CE; Gerding DN
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):127-36. PubMed ID: 3115671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ciprofloxacin alone and in combination with other antibiotics in a murine model of thigh muscle infection.
    Haller I
    Am J Med; 1987 Apr; 82(4A):76-9. PubMed ID: 3578333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of in vitro sensitivity to netilmicin and ceftizoxime on selected highly resistant flora in surgical intensive therapy].
    Pessione E; Alberghina A; Franchello A; Verna C; Olivero G
    Minerva Med; 1988 Feb; 79(2):133-6. PubMed ID: 3162558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.
    Chin NX; Neu HC
    Am J Med; 1987 Apr; 82(4A):58-62. PubMed ID: 3578330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Lee MY; Ko KS; Song JH; Peck KR
    J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases.
    Esposito S; Galante D; Barba D; Pennucci C; Limauro D
    Microbiologica; 1985 Apr; 8(2):197-204. PubMed ID: 3874342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.